Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Popliteal Plexus Block 10 vs 20 mL in TKA
NCT06908837Phase 4Completed
- Sponsor
- Regionshospitalet Silkeborg
- Start
- Apr 2025
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by Regionshospitalet Silkeborg. Primary endpoint: Total opioid consumption at 24 hours. Started Apr 2025; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06908837.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06908837.